Sorafenib with interferon alfa-2b as first-line treatment of advanced renal carcinoma: A phase II study of the southwest oncology group

Christopher W. Ryan, Bryan H. Goldman, Primo N. Lara, Philip C. Mack, Tomasz M. Beer, Catherine M. Tangen, Dianne Lemmon, Chong Xian Pan, Harry A. Drabkin, E. David Crawford

Research output: Contribution to journal › Article › peer-review

153 Scopus citations

Fingerprint

Dive into the research topics of 'Sorafenib with interferon alfa-2b as first-line treatment of advanced renal carcinoma: A phase II study of the southwest oncology group'. Together they form a unique fingerprint.

Medicine & Life Sciences